Skip to Content

Pancrease MT 10 (pancrelipase) Disease Interactions

There is 1 disease interaction with Pancrease MT 10 (pancrelipase):

Moderate

Pancrelipase (Includes Pancrease MT 10) ↔ hyperuricemia

Moderate Potential Hazard, Moderate plausibility. Applies to: Gout, Renal Dysfunction

Porcine-derived pancreatic enzyme products contain purines that may increase blood uric acid levels. Extremely high dosages of exogenous pancreatic enzymes have also been associated with hyperuricosuria and hyperuricemia. Therapy with pancrelipase should be administered cautiously in patients with preexisting hyperuricemia, gout, or renal impairment. Monitoring of serum uric acid levels is recommended.

References

  1. "Product Information. Ultrase (pancrelipase)." Scandipharm Inc, Birmingham, AL.
  2. "Product Information. Cotazym-S (pancrelipase)." Organon, West Orange, NJ.
  3. "Product Information. Ku-zyme (pancrelipase)." Schwarz Pharma, Mequon, WI.
  4. "Product Information. Creon 10 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA.
  5. "Product Information. Pancrease MT (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ.
  6. "Product Information. Creon 5 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA.
  7. "Product Information. Creon 20 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA.
  8. "Product Information. Viokase (pancrelipase)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  9. "Product Information. Cotazym (pancrelipase)." Organon, West Orange, NJ.
  10. "Product Information. Zymase (pancrelipase)." Organon, West Orange, NJ.
  11. "Product Information. Pancrease (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ.
  12. "Product Information. Ultrase MT (pancrelipase)." Scandipharm Inc, Birmingham, AL.
View all 12 references

Pancrease MT 10 (pancrelipase) drug interactions

There are 76 drug interactions with Pancrease MT 10 (pancrelipase)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide